drugset / Trial / NCT05763459
A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
This study follows an open-label, single arm design with two periods with rosuvastatin, digoxin and ABBV-CLS-7262
Timeline
- Start
- 2023-03-24
- Primary completion
- 2023-05-08
- Completion
- 2023-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-CLS-7262 | Unknown | — | — |
| Subject | Digoxin | Other / unclassified | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
Indications
No indication recorded.